Merck & Co., Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for MRK, updated each market day.
MRK AI Sentiment
AI sees no strong directional signal for Merck & Co., Inc. stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Sector
Exchange
Market Cap
$363,044,306,531
Cap Tier
Employees
75,000
Headquarters
RAHWAY, NJ
Listed Since
April 20, 1949
Website
MRK Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
MRK Volatility
Merck & Co., Inc. has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
